Trade Summary

5 days ago, Pande Atul, serving as Dir at Immunovant, Inc. (IMVT), sold 6,000 shares at $32.00 per share, for a total transaction value of $192,000.00. Following this transaction, Pande Atul now holds 136,731 shares of IMVT.

This sale represents a 4.00% decrease in Pande Atul's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, May 20, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 20, 2026 at 9:22 PM ET, meaning the disclosure happened on the same day as the trade.

Immunovant, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.